GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6

Updated on: May 26,2024 8

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6

Updated on:May 26,2024 8

Scientists map cancer-related proteins in unprecedented detail

byInstitute of Cancer ResearchStructures and interactions of the CSN–CRL2~N8 complex. Image also shows the molecular model of CSN–CRL2~N8 fitted into cryo-EM density (8.2 Å resolution) from fron

Updated on: December 22,2023 14

Scientists map cancer-related proteins in unprecedented detail

byInstitute of Cancer ResearchStructures and interactions of the CSN–CRL2~N8 complex. Image also shows the molecular model of CSN–CRL2~N8 fitted into cryo-EM density (8.2 Å resolution) from fron

Updated on:December 22,2023 14

Simple laser treatments may prevent nonmelanoma skin cancer

by Katie Marquedant,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainNew research indicates that simple laser treatments to the skin may help to prevent the development of basal ce

Updated on: December 26,2023 10

Simple laser treatments may prevent nonmelanoma skin cancer

by Katie Marquedant,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainNew research indicates that simple laser treatments to the skin may help to prevent the development of basal ce

Updated on:December 26,2023 10

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on: February 20,2024 14

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on:February 20,2024 14

Cancer mortality rates correlate to geography as well as known behavioral risk factors

byCase Western Reserve UniversityCredit: Unsplash/CC0 Public DomainResearchers at Case Western Reserve University have found that risk factors historically linked to cancer mortality vary region

Updated on: December 18,2023 10

Cancer mortality rates correlate to geography as well as known behavioral risk factors

byCase Western Reserve UniversityCredit: Unsplash/CC0 Public DomainResearchers at Case Western Reserve University have found that risk factors historically linked to cancer mortality vary region

Updated on:December 18,2023 10

Shorter course of radiation therapy yields comparable results for patients with non-metastatic soft tissue sarcoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely rec

Updated on: December 21,2023 10

Shorter course of radiation therapy yields comparable results for patients with non-metastatic soft tissue sarcoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely rec

Updated on:December 21,2023 10

Enzyme that protects against viruses could fuel cancer evolution

byWeill Cornell Medical CollegeA three-dimensional image of a cancer cell's nucleus obtained by Dr. Faltas and his team shows the APOBEC3G protein (green) inside the nucleus (blue). Credit:

Updated on: December 20,2023 10

Enzyme that protects against viruses could fuel cancer evolution

byWeill Cornell Medical CollegeA three-dimensional image of a cancer cell's nucleus obtained by Dr. Faltas and his team shows the APOBEC3G protein (green) inside the nucleus (blue). Credit:

Updated on:December 20,2023 10

Team of sister scientists identify a possible genetic culprit for uterine corpus endometrial cancer

by Allison Trouten,Medical University of South CarolinaMYO5B mRNA is elevated in uterine corpus endometrial carcinoma (UCEC) patients. A. The expression of MYO5B in various control tissues and t

Updated on: December 26,2023 10

Team of sister scientists identify a possible genetic culprit for uterine corpus endometrial cancer

by Allison Trouten,Medical University of South CarolinaMYO5B mRNA is elevated in uterine corpus endometrial carcinoma (UCEC) patients. A. The expression of MYO5B in various control tissues and t

Updated on:December 26,2023 10

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Updated on: July 13,2024 0

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Updated on:July 13,2024 0

Putting a dollar value on cancer survival

by University of the Sunshine CoastCredit: Pixabay/CC0 Public DomainNew University of the Sunshine Coast-led research has for the first time estimated the health care costs of Queenslanders who surviv

Updated on: February 20,2024 14

Putting a dollar value on cancer survival

by University of the Sunshine CoastCredit: Pixabay/CC0 Public DomainNew University of the Sunshine Coast-led research has for the first time estimated the health care costs of Queenslanders who surviv

Updated on:February 20,2024 14

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on: December 22,2023 24

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on:December 22,2023 24

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on: December 26,2023 10

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on:December 26,2023 10